TIM
QTTB icon

Thompson Investment Management’s Q32 Bio QTTB Stock Holding History

Thompson Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$7 – 503
2025
Q1 		$7 Hold
4
– – ﹤0.01% 481
2024
Q4 		$14 Hold
4
– – ﹤0.01% 494
2024
Q3 		$178 Hold
4
– – ﹤0.01% 487
2024
Q2 		$72 Hold
4
– – ﹤0.01% 492
2024
Q1 		$68 Hold
4
– – ﹤0.01% 509
2023
Q4 		$46 Hold
4
– – ﹤0.01% 420
2023
Q3 		$89 Hold
4
– – ﹤0.01% 400
2023
Q2 		$67 Hold
4
– – ﹤0.01% 404
2023
Q1 		$78 Buy
+4
New +$100 ﹤0.01% 394

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Thompson Investment Management's QTTB Position: Q2 2025 in Review

Thompson Investment Management sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 4 shares — an estimated $7 sold.

Thompson Investment Management first reported a position in QTTB in Q1 2023 and held it in 9 quarters. The position peaked at $178 in Q3 2024. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Thompson Investment Management reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Thompson Investment Management sold 4 Q32 Bio shares in Q2 2025, an estimated $7.
  • Thompson Investment Management first reported a position in Q32 Bio in Q1 2023 and held it in 9 quarters.
  • Thompson Investment Management's Q32 Bio position peaked at $178 in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Thompson Investment Management's 13F filing for Q2 2025, filed 24 Jul 2025.